Hepatitis due to Epstein–Barr virus and cytomegalovirus: clinical features and outcomes

References

• Fiala M, Heiner DC, Turner JA, et al. Infectious mononucleosis and mononucleosis syndromes: clinical, virological and immunological features. West J Med 1977;126:445–459.
   PubMedGoogle Scholar
• Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine (Baltimore). 1985;64:100–114.
   PubMed Web of Science ®Google Scholar
• Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007;120:911.e1–918.
   PubMed Web of Science ®Google Scholar
• Odumade OA, Hogquist KA, Balfour HH. Jr., Progress and problems in understanding and managing primary Epstein–Barr virus infections. Clin Microbiol Rev 2011;24:193–209.
   PubMed Web of Science ®Google Scholar
• Jacobson IM, Gang DL, Schapiro RH. Epstein-Barr viral hepatitis: an unusual case and review of the literature. Am J Gastroenterol 1984;79:628–632.
   PubMed Web of Science ®Google Scholar
• Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994;14:1–13.
   PubMedGoogle Scholar
• Papatheodoridis GV, Delladetsima JK, Kavallierou L, et al. Fulminant hepatitis due to Epstein–Barr virus infection. J Hepatol 1995;23:348–350.
   PubMed Web of Science ®Google Scholar
• Feranchak AP, Tyson RW, Narkewicz MR, et al. Fulminant Epstein–Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Trans 1998;4:469–476.
   Web of Science ®Google Scholar
• Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5:47.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Kim TH, Shim KN, et al. Infectious mononucleosis hepatitis in young adults: two case reports. Korean J Intern Med 2009;24:381–387.
   PubMedGoogle Scholar
• Drebber U, Kasper HU, Krupacz J, et al. The role of Epstein–Barr virus in acute and chronic hepatitis. J Hepatol 2006;44:879–885.
   PubMed Web of Science ®Google Scholar
• Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein–Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther 2012;36:16–21.
   PubMed Web of Science ®Google Scholar
• Shusterman NH, Frauenhoffer C, Kinsey MD. Fatal massive hepatic necrosis in cytomegalovirus mononucleosis. Ann Intern Med 1978;88:810–812.
   PubMed Web of Science ®Google Scholar
• Oku T, Maeda M, Waga E, et al. Cytomegalovirus cholangitis and pancreatitis in an immunocompetent patient. J Gastroenterol 2005;40:987–992.
   PubMed Web of Science ®Google Scholar
• Yu YD, Park GC, Park PJ, et al. Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case. Surg Today 2013;43:424–428.
   PubMed Web of Science ®Google Scholar
• Chan A, Bazerbachi F, Hanson B, et al. Cytomegalovirus hepatitis and pancreatitis in the immunocompetent. Ochsner J 2014;14:295–299.
   PubMedGoogle Scholar
• Qian JY, Bai XY, Feng YL, et al. Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis. WJG 2015;21:12505–12509.
   PubMed Web of Science ®Google Scholar
• Bjornsson HK, Olafsson S, Bergmann OM, et al. A prospective study on the causes of notably raised alanine aminotransferase (ALT). Scand J Gastroenterol 2016;51:594–600.
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Gill R, Horwitz CA, et al. Marked hyperbilirubinemia in infectious mononucleosis. Analysis of laboratory data in seven patients. Arch Intern Med 1987;147:850–853.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Peacock S, Juniper M, et al. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997;24:52–56.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Neau D, Viallard JF, et al. Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults. Ann Med Interne (Paris) 2001;152:227–235.
   PubMedGoogle Scholar
• Wreghitt TG1, Teare EL, Sule O, et al. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 2003;37:1603–1606.
   PubMed Web of Science ®Google Scholar
• Kwo PY, Cohen SM, Lim JK. ACG clinical guideline evaluation of evaluation of abnormal liver chemistries. Am J Gastroenterol 2017;112:18–35.
   PubMed Web of Science ®Google Scholar
• Björnsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 2010;32:3–13.
   PubMed Web of Science ®Google Scholar
• Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011;89:806–815.
   PubMed Web of Science ®Google Scholar
• Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323–1330.
   PubMed Web of Science ®Google Scholar
• Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993;46:1331–1336.
   PubMed Web of Science ®Google Scholar
• Aithal GP, Rawlins MD, Day CP. Accuracy of hepatic adverse drug reaction reporting in one English health region. BMJ 1999;319:1541
   PubMed Web of Science ®Google Scholar
• Cohen JI. Epstein–Barr virus infection. N Engl J Med 2000;343:[10.1056/NEJM200008173430707] 481–492.
   PubMed Web of Science ®Google Scholar
• Adams LA, Deboer B, Jeffrey G, et al. Ganciclovir and the treatment of Epstein–Barr virus hepatitis. J Gastroenterol Hepatol 2006;21:1758–1760.
   PubMed Web of Science ®Google Scholar
• Edoute Y, Baruch Y, Lachter J, et al. Severe cholestatic jaundice induced by Epstein–Barr virus infection in the elderly. J Gastroenterol Hepatol. 1998;13:821–824.
   PubMed Web of Science ®Google Scholar
• Hinedi TB, Koff RS. Cholestatic hepatitis induced by Epstein–Barr virus infection in an adult. Dig Dis Sci. 2003;48:539–541.
   PubMed Web of Science ®Google Scholar
• Khoo A. Acute cholestatic hepatitis induced by Epstein-Barr virus infection in an adult: a case report. J Med Case Rep 2016;10:75
   PubMedGoogle Scholar
• Poddighe D, Cagnoli G, Mastricci N, et al. Acute acalculous cholecystitis associated with severe EBV hepatitis in an immunocompetent child. BMJ Case Rep 2014. doi: 10.1136/bcr-2013-201166.
   Google Scholar
• Sanches F, Gimeno-Bayon JL, Esgueva R, et al. Fatal liver failure: molecular evidence for chronic active Epstein–Barr virus infection. Ann Diagn Pathol 2008;12:368–371.
   PubMed Web of Science ®Google Scholar
• Kunno A, Abe M, Yamada M, et al. Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults. Liver 1997;17:129–132.
   PubMedGoogle Scholar
• Serna-Higuera C, González-García M, Milicua JM, et al. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir. J Clin Gastroenterol 1999;29:276–277.
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Muñoz-Codoceo C, López-Medrano F, et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. Intern Med 2008;47:1963–1966.
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Olafsson S, Björnsdottir T, Löve A. Prevalence of hepatitis E among patients suspected of drug-induced liver injury, pig farm workers and in the general population of Iceland. Gastroenterology 2015;150:S1068–S1069.
   Web of Science ®Google Scholar